Medicine & AI to Improve Outcomes by Discovering Undiagnosed Patients- NHS Clinicians Presenting at HIMSS

Predicting Length-of-Stay & Risk of Mortality for ICU Patients

Pangaea Data Awarded Top Tier Co-Sell Partnership Status by Microsoft

Pangaea Named ‘Digital Solution of the Year’ by UK Government’s Department for International Trade

WHITEPAPER: How can Pharmaceutical & Healthcare Providers Collaborate in a Financially Sustainable & Scalable Manner to Improve Patient Outcomes?

Go back

Pangaea Appoints Mr. Joe Donahue and Dr. Ramon Felciano to its Scientific Advisory Board

The appointment of Mr. Donahue and Dr. Felciano to the Scientific Advisory Board will help to continue drive Pangaea's growth.

Dr. Vibhor Gupta, Founder and CEO of Pangaea Data stated “We are excited to announce that Mr. Joe Donahue and Dr. Ramon Felciano will be joining Pangaea’s Scientific Advisory Board (SAB). They bring a breadth of scientific and industry experience, and will be an invaluable part of our company’s growth.”

Mr. Joe Donahue
Managing Director, MediData; Former Managing Director, Accenture

Mr. Joe Donahue has more than thirty years of executive-level experience in global life sciences, technology, private equity and banking firms. Several of the roles he has held include Managing Partner for Medidata’s Acorn AI business, Managing Director Global Life Sciences R&D with Accenture and SVP at BioReference Laboratories/ GeneDx. 

Dr. Ramon Felciano
Founder, Ingenuity Systems (acquired by QIAGEN)

Dr. Ramon Felciano has a distinguished track record in entrepreneurship, innovation and executive management in the digital health and life sciences industries. Most recently, Ramon held the role of Chief Technology Officer and VP, Strategy for QIAGEN N.V. Prior to this, he founded Ingenuity Systems out of Stanford University and he has held several technology leadership roles at Stanford Medicine.